# Gilead Sciences (GILD) — Overview

GILD · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/gild

## Price

Last close $159.30 on Oct 15, 2026. 52-week range $117.85 – $159.30.

## Company profile

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $30.5B |
| Revenue (quarter) | $7.8B |
| Revenue growth (year over year) | 10.18% |
| Gross profit (trailing twelve months) | $24.2B |
| Gross margin | 79.59% |
| Net income (trailing twelve months) | −$3.2B |
| Net income (quarter) | −$10.5B |
| Net income growth (year over year) | -635.51% |
| Net margin | -10.64% |
| Return on equity | -20.57% |
| EPS (trailing twelve months) | −$2.61 |
| Book value per share | $9.53 |
| P/E (trailing twelve months) | — |
| Price to book | 16.8 |
| Debt to assets | 76.21% |
| Payout ratio | 46.14% |
| Dividend yield | 2.05% |

## Frequently Asked Questions

### Is Gilead Sciences (GILD) profitable?

No. Gilead Sciences reported a net loss of $3.2B over the trailing twelve months.

### How much revenue does Gilead Sciences (GILD) make?

Gilead Sciences generated $30.5B in revenue over the trailing twelve months, up 10.18% year over year.

### How do I buy stock in Gilead Sciences (GILD)?

GILD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

## Similar Stocks

- [VRTX](https://www.lighthorse.io/tickers/vrtx) — Vertex Pharmaceuticals Incorporated - Common Stock
- [PFE](https://www.lighthorse.io/tickers/pfe) — Pfizer, Inc. Common Stock
- [ABBV](https://www.lighthorse.io/tickers/abbv) — AbbVie Inc. Common Stock
- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock
- [MRK](https://www.lighthorse.io/tickers/mrk) — Merck & Company, Inc. Common Stock (new)
- [REGN](https://www.lighthorse.io/tickers/regn) — Regeneron Pharmaceuticals, Inc. - Common Stock
- [AMGN](https://www.lighthorse.io/tickers/amgn) — Amgen Inc. - Common Stock
- [LGND](https://www.lighthorse.io/tickers/lgnd) — Ligand Pharmaceuticals Incorporated - Common Stock
- [VIR](https://www.lighthorse.io/tickers/vir) — Vir Biotechnology, Inc. - Common Stock
- [BMY](https://www.lighthorse.io/tickers/bmy) — Bristol-Myers Squibb Company Common Stock

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).